Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
Clinical trial NCT05467514 · COMPLETED
Trial details
- NCT number
- NCT05467514
- Sponsor
- David Sanchez Garcia
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-02-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.